Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fananapazir

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Journal of the American College of Cardiology|December 29, 2000
Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac diseaseS A Mohiddin, D Begley, J Shih, et al.
Pacing and Clinical Electrophysiology : PACE|January 1, 1994
Radiofrequency catheter atrioventricular node ablation in patients with permanent cardiac pacing systemsA C Chang, D McAreavey, D Tripodi, et al.
British Heart Journal|September 1, 1987
Ventricular septal defect after myocardial infarction: assessment by cross sectional echocardiography with pulsed wave Doppler scanningD MacLeod, L Fananapazir, D de Bono, et al.
Lancet (London, England)|April 30, 1977
Raised urinary fibrin-degradation products, complement, and IgG during an influenza-like illnessL Fananapazir, M Eccleston, E Edmond, et al.
Circulation|June 1, 1992
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapyL Fananapazir, R O Cannon, D Tripodi, et al.
Circulation|August 1, 1992
Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutationN D Epstein, G M Cohn, F Cyran, et al.
Pacing and Clinical Electrophysiology : PACE|July 1, 1995
Relief of left ventricular outflow tract obstruction following inadvertent left ventricular apical pacing in a patient with hypertrophic cardiomyopathyA C Chang, W L Atiga, D McAreavey, et al.
Circulation|September 1, 1992
Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findingsL Fananapazir, A C Chang, S E Epstein, et al.
Journal of the American College of Cardiology|September 1, 1993
Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathyV Dilsizian, R O Bonow, S E Epstein, et al.
Journal of Muscle Research and Cell Motility|June 1, 1997
The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathyG Cuda, L Fananapazir, N D Epstein, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Journal of the American College of Cardiology|December 29, 2000
Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac diseaseS A Mohiddin, D Begley, J Shih, et al.
Pacing and Clinical Electrophysiology : PACE|January 1, 1994
Radiofrequency catheter atrioventricular node ablation in patients with permanent cardiac pacing systemsA C Chang, D McAreavey, D Tripodi, et al.
British Heart Journal|September 1, 1987
Ventricular septal defect after myocardial infarction: assessment by cross sectional echocardiography with pulsed wave Doppler scanningD MacLeod, L Fananapazir, D de Bono, et al.
Lancet (London, England)|April 30, 1977
Raised urinary fibrin-degradation products, complement, and IgG during an influenza-like illnessL Fananapazir, M Eccleston, E Edmond, et al.
Circulation|June 1, 1992
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapyL Fananapazir, R O Cannon, D Tripodi, et al.
Circulation|August 1, 1992
Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutationN D Epstein, G M Cohn, F Cyran, et al.
Pacing and Clinical Electrophysiology : PACE|July 1, 1995
Relief of left ventricular outflow tract obstruction following inadvertent left ventricular apical pacing in a patient with hypertrophic cardiomyopathyA C Chang, W L Atiga, D McAreavey, et al.
Circulation|September 1, 1992
Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findingsL Fananapazir, A C Chang, S E Epstein, et al.
Journal of the American College of Cardiology|September 1, 1993
Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathyV Dilsizian, R O Bonow, S E Epstein, et al.
Journal of Muscle Research and Cell Motility|June 1, 1997
The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathyG Cuda, L Fananapazir, N D Epstein, et al.
Pageof 7